mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.8 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.8 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |